Logo image of ALUCI.PA

LUCIBEL SA (ALUCI.PA) Stock Fundamental Analysis

EPA:ALUCI - Euronext Paris - Matif - FR0011884378 - Common Stock - Currency: EUR

0.0975  -0.01 (-9.05%)

Fundamental Rating

2

Taking everything into account, ALUCI scores 2 out of 10 in our fundamental rating. ALUCI was compared to 60 industry peers in the Electrical Equipment industry. ALUCI may be in some trouble as it scores bad on both profitability and health. ALUCI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALUCI had negative earnings in the past year.
ALUCI had a negative operating cash flow in the past year.
ALUCI had negative earnings in 4 of the past 5 years.
ALUCI had negative operating cash flow in 4 of the past 5 years.
ALUCI.PA Yearly Net Income VS EBIT VS OCF VS FCFALUCI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

ALUCI has a Return On Assets (0.72%) which is comparable to the rest of the industry.
ALUCI has a better Return On Equity (7.58%) than 63.33% of its industry peers.
ALUCI has a Return On Invested Capital of 2.63%. This is comparable to the rest of the industry: ALUCI outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA 0.72%
ROE 7.58%
ROIC 2.63%
ROA(3y)-17.28%
ROA(5y)-32.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALUCI.PA Yearly ROA, ROE, ROICALUCI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200 -300

1.3 Margins

The Profit Margin of ALUCI (0.81%) is comparable to the rest of the industry.
ALUCI has a Operating Margin of 1.48%. This is comparable to the rest of the industry: ALUCI outperforms 46.67% of its industry peers.
ALUCI has a better Gross Margin (64.39%) than 88.33% of its industry peers.
In the last couple of years the Gross Margin of ALUCI has grown nicely.
Industry RankSector Rank
OM 1.48%
PM (TTM) 0.81%
GM 64.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.76%
GM growth 5Y2.09%
ALUCI.PA Yearly Profit, Operating, Gross MarginsALUCI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALUCI is destroying value.
Compared to 1 year ago, ALUCI has more shares outstanding
Compared to 5 years ago, ALUCI has more shares outstanding
Compared to 1 year ago, ALUCI has an improved debt to assets ratio.
ALUCI.PA Yearly Shares OutstandingALUCI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
ALUCI.PA Yearly Total Debt VS Total AssetsALUCI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

ALUCI has an Altman-Z score of 0.39. This is a bad value and indicates that ALUCI is not financially healthy and even has some risk of bankruptcy.
ALUCI has a worse Altman-Z score (0.39) than 70.00% of its industry peers.
A Debt/Equity ratio of 2.28 is on the high side and indicates that ALUCI has dependencies on debt financing.
The Debt to Equity ratio of ALUCI (2.28) is worse than 86.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.28
Debt/FCF N/A
Altman-Z 0.39
ROIC/WACC0.39
WACC6.83%
ALUCI.PA Yearly LT Debt VS Equity VS FCFALUCI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

ALUCI has a Current Ratio of 0.90. This is a bad value and indicates that ALUCI is not financially healthy enough and could expect problems in meeting its short term obligations.
ALUCI's Current ratio of 0.90 is on the low side compared to the rest of the industry. ALUCI is outperformed by 85.00% of its industry peers.
ALUCI has a Quick Ratio of 0.90. This is a bad value and indicates that ALUCI is not financially healthy enough and could expect problems in meeting its short term obligations.
ALUCI has a worse Quick ratio (0.47) than 86.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.47
ALUCI.PA Yearly Current Assets VS Current LiabilitesALUCI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 102.22% over the past year.
The Revenue has grown by 10.49% in the past year. This is quite good.
ALUCI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.24% yearly.
EPS 1Y (TTM)102.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-662.24%
Revenue 1Y (TTM)10.49%
Revenue growth 3Y-3.96%
Revenue growth 5Y2.24%
Sales Q2Q%-37.28%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALUCI.PA Yearly Revenue VS EstimatesALUCI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B 25B
ALUCI.PA Yearly EPS VS EstimatesALUCI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 0.2 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ALUCI.PA Price Earnings VS Forward Price EarningsALUCI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALUCI.PA Per share dataALUCI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALUCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LUCIBEL SA

EPA:ALUCI (3/7/2025, 7:00:00 PM)

0.0975

-0.01 (-9.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)04-23 2024-04-23
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4.87%
Ins Owner ChangeN/A
Market Cap3.46M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B 3.59
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.25
BVpS0.03
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.72%
ROE 7.58%
ROCE 3.61%
ROIC 2.63%
ROICexc 3.5%
ROICexgc N/A
OM 1.48%
PM (TTM) 0.81%
GM 64.39%
FCFM N/A
ROA(3y)-17.28%
ROA(5y)-32.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.76%
GM growth 5Y2.09%
F-Score5
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 2.28
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 9.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.47
Altman-Z 0.39
F-Score5
WACC6.83%
ROIC/WACC0.39
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)6.54%
Cap/Sales(5y)5.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-662.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.49%
Revenue growth 3Y-3.96%
Revenue growth 5Y2.24%
Sales Q2Q%-37.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y105.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.72%
OCF growth 3YN/A
OCF growth 5YN/A